Dr. Merve Postalcioglu, MD

Dr. Postalcioglu practices at Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA.

Dr. Postalcioglu's NPI, 1316442056, was assigned on March 26, 2018. Dr. Postalcioglu holds California license A173794.

Dr. Postalcioglu's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center, at 1001 Potrero Avenue, San Francisco, CA 94110 in San Francisco County. The practice phone is (415) 206-8000.

Dr. Postalcioglu's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA. Dr. Postalcioglu is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Postalcioglu to 1 more hospital and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Postalcioglu practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Postalcioglu's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Postalcioglu is licensed in California.

CMS data shows 201 Medicare services from Dr. Postalcioglu across 6 procedure codes in 2024, for 110 Medicare patients. Medicare paid $14,870 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 110 Medicare patients who saw Dr. Postalcioglu in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 56% are also on Medicaid. Their average risk score is 4.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Postalcioglu's median patient age at 68, with 40% women.

In 2024, Dr. Postalcioglu wrote 33 Medicare Part D claims for 18 patients. 85% of them were for generic drugs. They cover 19 drugs, with $10,366 in total drug cost. In 2020, CMS named 822 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Postalcioglu for performance year 2024, reported as part of a group. Dr. Postalcioglu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Postalcioglu as offering telehealth.

Dmand AI links 5 papers to Dr. Postalcioglu, published from 2018 to 2024. 2024 was the busiest year, with 2. Dr. Postalcioglu's most frequent co-authors are Joachim Hanno Ix, MD, Michael George Shlipak, MD and Joseph Harry Antin, MD.